32704300|t|The interface of psychiatry and COVID-19: Challenges for management of psychiatric patients.
32704300|a|COVID-19 is a viral infection that has multisystemic physical and psychological complications. The following paper looks at the various challenges seen while treating psychiatric patients during the COVID pandemic. There is a need for physician to be aware of the drug interactions between psychiatric medications and the medications used routinely in the management of COVID. There is also the concern of psychiatric side effects of medications used to manage COVID and medical complications caused by some side effects of psychiatric drugs. The telepsychiatry and telemedicine paradigm has made it mandatory for physicians to be vigilant of the same.
32704300	32	40	COVID-19	Disease	MESH:D000086382
32704300	71	82	psychiatric	Disease	MESH:D001523
32704300	83	91	patients	Species	9606
32704300	93	101	COVID-19	Disease	MESH:D000086382
32704300	107	122	viral infection	Disease	MESH:D014777
32704300	260	271	psychiatric	Disease	MESH:D001523
32704300	272	280	patients	Species	9606
32704300	292	297	COVID	Disease	MESH:D000086382
32704300	383	406	psychiatric medications	Chemical	-
32704300	463	468	COVID	Disease	MESH:D000086382
32704300	499	510	psychiatric	Disease	MESH:D001523
32704300	554	559	COVID	Disease	MESH:D000086382
32704300	617	634	psychiatric drugs	Disease	MESH:D001523

